Results 211 to 220 of about 1,472,301 (348)

Association of CMTM6 expression with clinicopathological characteristics and prognostic implications in renal cell carcinoma. [PDF]

Ther Adv Med Oncol
Tulchiner G, Fritz J, Rehder P, Bektic J, Zelger B, Jelisejevas L, Brunner A, Ladurner M.   +7 more
europepmc   +1 more source

Proliferative behaviour and cytogenetic changes in human renal-cell carcinoma [PDF]

, 1991
Allhoff, E. P., Azpodien, J., Djamilian, Mohamad H., Jonas, Udo, Kirchner, H., Riese, W. de, Schlick, R. W., Stief, Christian Georg, Werner, M.   +8 more
core   +1 more source

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Science, 2018
Diana Miao, Claire A. Margolis, Wenhua Gao, M. Voss, Wei Li, D. Martini, Craig K. Norton, D. Bossé, Stephanie A. M. Wankowicz, D. Cullen, C. Horak, M. Wind-Rotolo, A. Tracy, M. Giannakis, F. Hodi, C. Drake, M. Ball, M. Allaf, A. Snyder, M. Hellmann, T. Ho, R. Motzer, S. Signoretti, W. Kaelin, T. Choueiri, E. V. Van Allen   +25 more
semanticscholar   +1 more source

5‐Methylcytosine Analysis of miRNAs in Minimal Change Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Minimal change disease (MCD) is a glomerular disorder, which is the most common cause of nephrotic syndrome in children. Additionally, the prevalence of MCD in adults has been increasing in recent years. During protein synthesis, noncoding RNAs can be regulated through a variety of modifications, which helps preserve biological diversity and ...
Huiyi Zeng, Dandan Li, Yunyi Li, Chen Yun, Xinzhou Zhang, Wenyu Gong, Mengyun Xiao, Haitao Li, Zhipeng Zeng, Ruqi Tan, Yishen Yang, Shaodong Luan, Yong Dai, Lianghong Yin, Donge Tang   +14 more
wiley   +1 more source

Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application. [PDF]

Front Immunol
Kagirova E, Enikeeva K, Mukhamadeev R, Asadullina D, Sharifyanova Y, Shmelkova P, Gainullina D, Trifonova D, Gattinger P, Docena G, Dubovets A, Tulaeva I, Karaulov A, Valenta R, Pavlov V.   +14 more
europepmc   +1 more source

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

Nature Reviews Nephrology, 2020
E. Jonasch, C. Walker, W. Rathmell
semanticscholar   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

A Case of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus Achieving Pathologic Complete Response Following Combination Therapy With Lenvatinib and Pembrolizumab. [PDF]

IJU Case Rep
Takayama H, Sano T, Hirao K, Motoki Y, Taniguchi H, Yanishi M, Uchida K, Kinoshita H.   +7 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Renal capillary hemangioma mimicking renal cell carcinoma: A diagnostic pitfall. [PDF]

Urol Case Rep
Huynh QH, Bui PA, Mai Ba TD, Pham Vu DH, Tran VT, Tong Thi MK, Nguyen CP.   +6 more
europepmc   +1 more source